Curaleaf Holdings (CURLF) Other Non-Current Liabilities (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Other Non-Current Liabilities of $531.5 million in Q4 2025, up 8546.62% quarter-over-quarter from $6.1 million in Q4 2024, and up 8546.62% on a YoY basis from $6.1 million in Q4 2024.
Curaleaf Holdings (CURLF) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $531.5 million for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities rose 8546.62% year-over-year to $531.5 million; the TTM figure through Dec 2025 stood at $531.5 million (up 8546.62% YoY), while the FY2025 annual figure was $531.5 million, up 8546.62% from the prior year.
- Other Non-Current Liabilities was $531.5 million for Q4 2025 at Curaleaf Holdings, up from $6.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $6.6 billion in Q1 2022 to a low of $3.8 million in Q3 2022.
- Historically, Other Non-Current Liabilities has averaged $531.5 million across 5 years, with a median of $7.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities jumped 170914.49% in 2022, then sank 83.77% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $38.0 million in 2021, then decreased by 23.38% to $29.1 million in 2022, then tumbled by 83.77% to $4.7 million in 2023, then surged by 30.12% to $6.1 million in 2024, then jumped by 8546.62% to $531.5 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $531.5 million (Q4 2025), $6.1 million (Q4 2024), and $378.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 531.51 Mn |
| Dec 31, 2024 | 6.15 Mn |
| Sep 30, 2024 | 378.19 Mn |
| Jun 30, 2024 | 339.82 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 7.01 Mn |
| Dec 31, 2022 | 29.11 Mn |
| Sep 30, 2022 | 3.80 Mn |
| Jun 30, 2022 | 9.38 Mn |
| Mar 31, 2022 | 6.61 Bn |
| Dec 31, 2021 | 37.99 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 4.10 Mn |
| Mar 31, 2021 | 3.86 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Sep 30, 2020 | 246,000.00 |
| Dec 31, 2019 | 32.62 Mn |